Study finds Pfizer's RSV vaccine not tied to higher risk of pre-term births

Pfizer's (PFE.N) respiratory syncytial virus (RSV) vaccine for pregnant women was not tied to a higher risk of pre-term or early births, according to a study published on Monday that analyzed real-world use of the shots.